Central Illinois Hematology Oncology Conference

Peoria, IL US
April 5, 2025

The Central Illinois Hematology Oncology Conference is an accredited continuous education to improve the care of cancer patients by educating cancer care providers about precision-guided management in hematology and oncology. Regional and national experts in the field will share comprehensive insights into the actionable molecular variations seen in common cancers. The event's format is tailored to promote active learning, enhance knowledge retention, and encourage practitioners to apply fresh insights into their clinical routines. Through didactics, case-centric discussions, and lively Q&A sessions, attendees can gain clarity, address uncertainties, and interact with the field's pioneers. This conference aims to provide physicians, physician assistants, nurse practitioners, pharmacists, nurses, and other healthcare professionals with the latest updates in hematology and oncology.  It will highlight a multidisciplinary approach and the integration of new advances in patient-centered care.

Target Audience

  • Hematologists/ Oncologists
  • Oncology Fellows
  • NPs/PAs
  • Pharmacists
  • Nurses
  • Researchers and others

Organizing Committee 

Course Director:

Binay Shah, MD, MHA - Binaytara Foundation

Conference Chair

Krishna Rao, MD, PhD - Southern Illinois University School of Medicine

Organizing Committee

Noor Naffakh, PharmD - University of Illinois, Chicago

Rakesh Mandal, MD - OSF Healthcare

Kimberly Ku, MD - Illinois CancerCare

Learning Objectives

Upon successful completion of this educational activity, participants will be able to:

  • Review common molecular abnormalities in various cancers and the optimal timing to test for these abnormalities.
  • Interpret the findings from next-generation sequencing and other biomarkers that indicate the likelihood of response to specific therapies while also understanding the inherent challenges.
  • Apply optimal strategies centered on molecular-targeted treatments in the management of patients with cancer.
  • Summarize emerging research, the mechanism of action, and the significance of new molecular-targeted treatments in managing cancer patients.

Hotel Information

Coming soon

GLOBAL ONCOLOGY PROJECT

Click this link to learn more about our ongoing project building a 200-bed cancer hospital in Nepal: https://binayfoundation.org/cancer-hospital/

You may also be interested in

Summit on Cancer Health Disparities (SCHD25)

The Summit on Cancer Health Disparities 2025 (SCHD25) is a premier annual event focused on addressing cancer health disparities. The conference serves to bridge research and practice, offering practical strategies to improve cancer care delivery and outcomes.
Course summary
Available credit: 
  • 6.00 ABIM MOC II
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.00 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • 6.00 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 6.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 6.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 6.00 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 6.00 Contact Hours.
Course opens: 
09/17/2024
Course expires: 
07/05/2025
Event starts: 
04/05/2025 - 8:00am PDT
Event ends: 
04/05/2025 - 5:00pm PDT
Cost:
$150.00
Add to calendar: 

April 5, 2025

All times below are listed in Central Standard Time (CST).

07:00 AM – 08:00 AM  Registration, Breakfast, & Exhibits

08:00 AM – 08:05 AM  Welcome 

08:05 AM – 08:20 AM  Binaytara Foundation's Efforts in Improving Cancer Care Disparities - Binay Shah, MD, MHA

08:20 AM – 09:10 AM  Session 1 - Precision Oncology: Innovations and Foundations

Session Chair: Krishna Rao, MD, PhD

08:20 AM – 08:35 AM  Circulating Tumor DNA (ctDNA): Current applications and future directions - Frank Weinberg, MD, PhD

08:35 AM – 09:10 AM  Case-Based Discussion - Peng Wang, MD

09:10 AM – 10:25 AM  Session 2 - Hematology: Precision Strategies for Blood Disorders

Session Chair: James L. Wade III, MD, FACP, FASCO & Waqas Azhar, MD 

09:10 AM – 09:30 AM  Precision Oncology in Multiple Myeloma - Matías E. Sánchez, MD

09:30 AM – 09:50 AM  Molecular-Directed Management of Myeloid Disorders - Guru Subramanian Guru Murthy, MD, MS

09:50 AM – 10:10 AM  Personalized Treatment in CLL - Parameswaran Venugopal, MD

10:10 AM – 10:25 AM  Panel Discussion - Rakesh Mandal, MD

10:25 AM – 10:45 AM  Break & Exhibits

10:45 AM – 11:45 AM  Session 3 - Breast Cancer: Tailored Treatments

Session Chair: Nusayba Bagegni, MD

10:45 AM – 11:10 AM  Genomics in Breast Cancer: From Biomarkers to Clinical Decisions - Praveen Vikas, MD, FACP, FASCO

11:10 AM – 11:45 AM  Case-Based Discussion: Precision Oncology in Early-Stage and Metastatic Breast Cancer - Noor Naffakh, PharmD

11:45 AM – 12:45 PM  Lunch & Exhibits

12:45 PM – 01:45 PM  Session 4 - GU Oncology

Session Chair: Kimberly Ku, MD

12:45 PM – 01:10 PM  Recent Advances in Molecular Guided Treatment of GU Cancers - Ariel Nelson, MD, MS

01:10 PM – 01:45 PM  Case-Based Discussion: Personalizing GU Cancer Management - Kimberly Ku, MD; Randy Sweis, MD

01:45 PM – 02:45 PM  Session 5 - Lung Cancer

Session Chair: Ryan Nguyen, DO

01:45 PM – 02:10 PM  Precision-Guided Therapeutics in Lung Cancer - Koosha Paydary, MD, MPH, MSc

02:10 PM – 02:45 PM  Case-Based Discussion: Biomarker-Driven Treatment in NSCLC -  Faith Abodunrin, MD; Nan Sethakorn, MD, PhD

02:45 PM – 03:15 PM  Break & Exhibits

03:15 PM – 04:15 PM  Session 6 - GI Oncology 

Session Chair:

03:15 PM – 03:40 PM  Management of GI Cancers in the Era of Precision Oncology - Ardaman Shergill, MD

03:40 PM – 04:15 PM  Case-Based Discussion: Emerging Targets and Treatment Approaches in GI Oncology - Manik Amin, MD

04:15 PM – 04:20 PM  Adjourn

Peoria Marriott Pere Marquette
501 Main St
Peoria, IL 61602
United States

Faculty Information Coming Soon

 

Available Credit

  • 6.00 ABIM MOC II
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.00 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • 6.00 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 6.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 6.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 6.00 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 6.00 Contact Hours.

If you are interested in exhibiting at this meeting, please visit our exhibit page here - https://education.binayfoundation.org/exhibit-information

 

Price

Cost:
$150.00
Please login or register to take this course.

POLICY ON INDUSTRY EMPLOYEE'S PARTICIPATION IN MARKETING/EDUCATION ACTIVITY AT THE CONFERENCE: 

All marketing and product promotion activities must occur in the designated exhibit hall or product theater space separate from the area where this accredited continuing education takes place. 

The exhibit and product promotion space is reserved only for companies that have purchased marketing and product promotion slots at the conference.  The individual registration fee doesn't include marketing or product theater privileges. Please refer to the sponsorship handbook for the types of marketing activities included in your display/sponsorship fees. 

If your company has NOT purchased a marketing opportunity such as an exhibit table, product theater slot or another type of marketing opportunity, you may not participate in any marketing activity or attempt to educate healthcare providers about your product or service. Industry attendees of companies without marketing opportunities must refrain from interacting with healthcare providers at this meeting in any form, including introducing themselves as an employee of the company, discussing the care of patients, handing out flyers and brochures, inviting participants to the company's other programs, etc.

Violating this policy will result in a fine equivalent to a general display fee for that conference. 

 

NOTICE TO HCPS EMPLOYED BY THE INDUSTRY:

If you are employed by industry, including pharmaceuticals and biotech companies, you must pay the INDUSTRY REGISTRATION FEE to participate in any meeting organized by the Binaytara Foundation. If you misrepresented yourself as a healthcare provider not employed by the industry and failed to pay the Industry registration fee, the following fees apply:

  • If your company has purchased a display table at the event, you will be billed the full INDUSTRY REGISTRATION FEE plus a fine equivalent to the full industry registration fee for that event = 2 X the industry registration fee.
  • If your company has NOT purchased a display table at the event AND you attended the meeting without paying a full industry registration fee, you will be billed a full GENERAL DISPLAY FEE for that event. 
  • If your company has NOT purchased a display table at the event AND you attended the meeting paying a full industry registration fee, BUT YOU PARTICIPATED IN MARKETING AND PROMOTIONAL ACTIVITIES, you will be billed a full GENERAL DISPLAY FEE for that event. 

Any outstanding display fee, registration fee, and fines must be paid before the industry employee or the company will be able to attend/display at our conferences again.

CANCELLATION POLICY

You may cancel your enrollment at any time. Cancellation fees apply as below:

  • 50% of the paid registration fee will be refunded if registration is canceled six weeks before the conference.
  • No refunds will be issued if registration is canceled after that date.  

No credits will be offered if you do not complete all required steps of this activity, including registration and participation in the live meeting.